申请人:TAISHO PHARMACEUTICAL CO. LTD
公开号:EP0458654A1
公开(公告)日:1991-11-27
Carbazole compounds having antipsychotic activity having the formula
(wherein R¹ is a hydrogen atom or an alkyl group having 1 to 5 carbon atoms; R² is a hydrogen atom, an alkyl group having 1 to 5 carbon atoms, an alkanoyl group having 2 to 6 carbon atoms or a benzoyl group; R³ and R⁴ are the same or are different, and each is a hydrogen atom, an alkyl group having 1 to 7 carbon atoms, an alkenyl group having 2 to 4 carbon atoms, an alkyl group having 1 to 3 carbon atoms substituted by a phenyl group, or R³ and R⁴ together with the adjacent nitrogen atom form a morpholino group, a piperidino group, a pyrrolidino group or a piperazino group; and n is an integer from 1 to 3), or a salt thereof.
具有抗精神病活性的咔唑化合物,其式为
(其中 R¹ 是氢原子或具有 1 至 5 个碳原子的烷基;R² 是氢原子、具有 1 至 5 个碳原子的烷基、具有 2 至 6 个碳原子的烷酰基或苯甲酰基;R³ 和 R⁴ 相同或不同,且各自为氢原子、具有 1 至 7 个碳原子的烷基、具有 2 至 4 个碳原子的烯基、具有 1 至 3 个碳原子的被苯基取代的烷基,或 R³ 和 R⁴ 与相邻的氮原子一起形成吗啉基、哌啶基、吡咯烷基或哌嗪基;且 n 为 1 至 3 的整数),或其盐。